Sleep Cycle (Q1 Interview): Transitioning toward a high-Potential health platform
Igår, 09:20
Sleep Cycle’s Q1 2026 report highlights a pivotal transition from a consumer-focused app to a diversified health platform. While distribution headwinds on the Apple Store have impacted short-term growth, the B2B segment continues to gain momentum, now accounting for nearly 15% of total revenue. In this interview, CEO Erik Jivmark discusses the stabilisation of Google Play, the massive expansion of the company’s Total Addressable Market (TAM), and the roadmap toward FDA approval for sleep apnea.
Ämnen i artikeln
Sleep Cycle (Q1 Interview): Transitioning toward a high-Potential health platform
Igår, 09:20
Sleep Cycle’s Q1 2026 report highlights a pivotal transition from a consumer-focused app to a diversified health platform. While distribution headwinds on the Apple Store have impacted short-term growth, the B2B segment continues to gain momentum, now accounting for nearly 15% of total revenue. In this interview, CEO Erik Jivmark discusses the stabilisation of Google Play, the massive expansion of the company’s Total Addressable Market (TAM), and the roadmap toward FDA approval for sleep apnea.
Ämnen i artikeln
Analys
Rapporter
Analys
Rapporter
Marknadsöversikt
1 DAG %
Senast
1 mån
